BD BBL Mueller Hinton II Broth (Cation-Adjusted); BD Difco Mueller Hinton Broth
Becton Dickinson and Company · Decision date Sep 14, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-14 for K262163, a traditional 510(k) submitted 06/26/2026 by Becton Dickinson and Company of Sparks, Maryland. The device is BD BBL Mueller Hinton II Broth (Cation-Adjusted) and BD Difco Mueller Hinton Broth, classified under 21 CFR 866.1700 as culture media for antimicrobial susceptibility testing, product code JTZ, in the microbiology specialty. SESE denotes clearance to market, not PMA approval.
A partial review excerpt describes an intended use in manual, quantitative susceptibility testing of rapidly growing aerobic bacteria and cites CLSI M07-Ed12 (March 2024). The available record does not specify which broth formulation or configuration was the subject of the change, the review's performance results, or any limitations FDA placed on the clearance; the decision summary itself was not captured.
The page was last updated 09/21/2026. No clinical performance, comparative, or labeling conclusions are drawn here beyond the recorded decision.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Microbiology
- Decision date
- Sep 14, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262163
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Becton Dickinson and Company
- Product code
- JTZ
- Decision code
- SESE
- Decision date
- Sep 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Culture Media, Antimicrobial Susceptibility Test, Mueller Hinton Agar/Broth.
- Applicant
- Becton Dickinson and Company
- Product code
- JTZ
- FDA device class
- 2
FDA decision timeline
K262163 received
Application receipt date recorded by FDA.
K262163 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Becton Dickinson and Company
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Sparks, MD
Sources and methodology
- Original FDA record: K262163
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records